We were appealed by the possibility to use of ISX for promoting caveolin and cavin expression as this could be of use for therapy of e.g. muscular dystrophy caused by CAV3 mutations, and therefore set out to determine its effect on these genes. Here, CAVIN1 is linked to muscular dystrophy.